HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadafumi Kato Selected Research

nervonic acid

1/2021Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study.
1/2018Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadafumi Kato Research Topics

Disease

82Bipolar Disorder (Manic Depressive Psychosis)
07/2022 - 03/2000
42Schizophrenia (Dementia Praecox)
07/2022 - 02/2003
19Mental Disorders (Mental Disorder)
01/2021 - 08/2003
13Mood Disorders (Mood Disorder)
01/2021 - 12/2006
9Mitochondrial Diseases (Mitochondrial Disease)
01/2018 - 10/2004
6Psychotic Disorders (Schizoaffective Disorder)
01/2021 - 08/2005
5Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2009 - 11/2002
4Major Depressive Disorder (Major Depressive Disorders)
01/2021 - 12/2012
3Inflammation (Inflammations)
01/2022 - 01/2018
3Anxiety Disorders (Anxiety Disorder)
12/2020 - 11/2002
3Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
10/2018 - 04/2005
3Parkinson Disease (Parkinson's Disease)
01/2018 - 08/2006
2Genetic Risk Score
07/2022 - 11/2021
2Psychomotor Agitation (Akathisia)
08/2021 - 12/2020
2Nausea
08/2021 - 12/2020
2Neuroblastoma
01/2015 - 11/2013
2Alzheimer Disease (Alzheimer's Disease)
02/2008 - 08/2006
2Neoplasms (Cancer)
02/2008 - 08/2006
2Medically Unexplained Symptoms
02/2007 - 12/2004
2MELAS Syndrome (Syndrome, MELAS)
08/2005 - 03/2005
2Poisoning
06/2005 - 11/2002
2Hyperventilation
10/2004 - 01/2003
1Necrosis
03/2022
1Nasopharyngitis
08/2021
1Sleepiness
08/2021
1Tourette Syndrome (Tourette's Syndrome)
05/2021
1Dementia (Dementias)
05/2021
1Mania (Manias)
01/2021
1Treatment-Resistant Depressive Disorder
01/2020
1Autism Spectrum Disorder
01/2018
1Darier Disease (Darier's Disease)
08/2016

Drug/Important Bio-Agent (IBA)

26Mitochondrial DNA (mtDNA)IBA
01/2022 - 12/2003
23LithiumIBA
07/2022 - 03/2000
14DNA (Deoxyribonucleic Acid)IBA
02/2015 - 01/2005
12Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2004
9CalciumIBA
01/2021 - 06/2003
7Biological ProductsIBA
09/2019 - 11/2002
7Messenger RNA (mRNA)IBA
02/2010 - 02/2003
6Pharmaceutical PreparationsIBA
01/2021 - 03/2000
6Hemoglobins (Hemoglobin)IBA
10/2004 - 04/2002
5Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2007
5Antidepressive Agents (Antidepressants)IBA
01/2020 - 10/2005
5Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2013 - 09/2004
5SarinIBA
01/2007 - 11/2002
4Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 12/2003
4Serotonin (5 Hydroxytryptamine)IBA
09/2019 - 07/2010
3Lurasidone HydrochlorideFDA Link
08/2021 - 12/2020
3Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
12/2020 - 07/2013
3NucleotidesIBA
05/2015 - 12/2004
3Valproic Acid (Depakote)FDA LinkGeneric
11/2013 - 01/2009
35-HT2C Serotonin ReceptorIBA
04/2008 - 08/2003
2EnzymesIBA
03/2022 - 12/2019
2CytokinesIBA
03/2022 - 01/2018
2Interleukin-6 (Interleukin 6)IBA
03/2022 - 01/2022
2nervonic acidIBA
01/2021 - 01/2018
2Dopamine (Intropin)FDA LinkGeneric
01/2021 - 09/2019
2DNA Polymerase gammaIBA
08/2017 - 11/2010
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2015 - 02/2005
2hydrogen sulfite (bisulfite)IBA
01/2015 - 11/2013
2Transcription Factors (Transcription Factor)IBA
01/2013 - 06/2005
2Serotonin ReceptorsIBA
02/2010 - 07/2009
2Therapeutic UsesIBA
01/2009 - 08/2007
2glucose-regulated proteinsIBA
01/2009 - 01/2007
2TungstenIBA
06/2008 - 02/2003
2Electron Transport Complex I (NADH-CoQ Reductase)IBA
04/2006 - 10/2004
2Cholinesterases (Cholinesterase)IBA
06/2005 - 11/2002
2Phosphorus (Red Phosphorus)IBA
04/2005 - 02/2004
1Interleukin-8 (Interleukin 8)IBA
03/2022
1Interleukin-4 (Interleukin 4)IBA
03/2022
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2022
1InterleukinsIBA
03/2022
1Interleukin-2 (IL2)IBA
03/2022
1ImmunosorbentsIBA
03/2022
1asenapineFDA Link
05/2021
1HLA-DRB1 Chains (HLA DRB1)IBA
01/2021
1HLA-DQB1 antigen (HLA DQB1)IBA
01/2021
1Protons (Proton)IBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1Cholinergic Agents (Cholinergics)IBA
11/2020
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
12/2019
1Sulfides (Thioethers)IBA
12/2019
1polysulfideIBA
12/2019
1Anticonvulsants (Antiepileptic Drugs)IBA
09/2019
1Adenine Nucleotide Translocator 1IBA
10/2018
1MicroRNAs (MicroRNA)IBA
01/2018
1Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2018
1AntigensIBA
01/2018
1Betaine (C.B.B.)FDA Link
02/2017
1Codon (Codons)IBA
08/2016
1Adenosine Triphosphatases (ATPase)IBA
08/2016
1Initiator Codon (Start Codon)IBA
08/2016
1Carrier Proteins (Binding Protein)IBA
02/2015
1Potassium Channels (Potassium Channel)IBA
02/2015
1ChromatinIBA
02/2015
1Fragile X Mental Retardation ProteinIBA
02/2015
1Adenosine Monophosphate (AMP)IBA
02/2015
1Quetiapine Fumarate (Seroquel)FDA Link
01/2015
1Poly I-CIBA
01/2014
1Epidermal Growth Factor (EGF)IBA
01/2014

Therapy/Procedure

2Therapeutics
11/2021 - 01/2021